Biogen Stock Quote
$333.00 -$1.25 -0.4%
Price as of February 14, 2020, 4:30 p.m. EST View Interactive BIIB Charts

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

News & Analysis: Biogen

The Fool has written over 700 articles on Biogen.


Market Moves



Better Buy: Biogen vs. Bristol-Myers Squibb

Does the potential of a home run for Biogen with its Alzheimer's disease candidate outweigh the strong lineup and pipeline that Bristol-Myers Squibb offers?

Is Biogen Stock a Buy?

Biogen handily beat expectations in the fourth quarter, but that doesn't mean this biotech stock is worth buying today.

Interactive Chart